Spondylodiscitis and ozone therapy. Case report
Case report Author MSc. Luisa B. Lima Hernández Dr. Norbery J. Rodríguez de la Paz Dr....
Read MoreSelect Page
Posted by AEPROMO | 30 May, 2022 | Volume 12 (2022) |
Case report Author MSc. Luisa B. Lima Hernández Dr. Norbery J. Rodríguez de la Paz Dr....
Read MorePosted by AEPROMO | 30 May, 2022 | Volume 12 (2022) |
Case report Author R. Farfaglia B. Antonini A. Bussi R. Pelizzari G. Martínez-Sánchez A....
Read MorePosted by AEPROMO | 30 May, 2022 | Volume 12 (2022) |
Case report Author Ubiratan Ferreira de Campos, Francisco Nogales, Carlos Goes Moraes,...
Read MorePosted by AEPROMO | 30 May, 2022 | Volume 12 (2022) |
Case report Author AJ Boyajian Abstract The use of ozone has been well documented in...
Read MorePosted by AEPROMO | 30 May, 2022 | Volume 12 (2022) |
Case report Author Ivonne Jiménez Rojas Abstract Context: The complications of Diabetes...
Read MoreVolume 13 (2023) STRONG TRIUMPH OF DRA. ADRIANA SCHWARTZ AND AEPROMO IN FAVOR OF OZONE THERAPY
Volume 11 (2021) Who decides what a pseudo-therapy is? Evidence vs hasty opinions on ozone
Volume 11 (2021) Does the United States Drug Agency (FDA) make scientific decisions?
Volume 2 (2012) RECTAL INSUFFLATIONS ARE A VALID WAY IN OZONETHERAPY
If you wish to submit your paper, please read our Publication Guidelines carefully
AEPROMO y Ozone Therapy Global Journal tiene entre sus primeras prioridades garantizar la ética y calidad de los artículos publicados.
Como compromiso con la comunidad científica, suscribimos el código de conducta y las buenas prácticas definidas por el Comité sobre la Ética de la Publicación (COPE) para editores de revistas científicas.
Este código se puede consultar en este enlace: Code of Conduct for Journal Editors